BioRestorative Therapies (BRTX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for BioRestorative Therapies (BRTX) over the last 12 years, with Q3 2025 value amounting to $2.0 million.

  • BioRestorative Therapies' Cash from Investing Activities rose 11325.13% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 82804.22%. This contributed to the annual value of $514529.0 for FY2024, which is 8417.83% down from last year.
  • Latest data reveals that BioRestorative Therapies reported Cash from Investing Activities of $2.0 million as of Q3 2025, which was up 11325.13% from $2.1 million recorded in Q2 2025.
  • BioRestorative Therapies' 5-year Cash from Investing Activities high stood at $3.0 million for Q2 2024, and its period low was -$9.9 million during Q3 2022.
  • Over the past 4 years, BioRestorative Therapies' median Cash from Investing Activities value was $819030.0 (recorded in 2023), while the average stood at -$209099.1.
  • Examining YoY changes over the last 5 years, BioRestorative Therapies' Cash from Investing Activities showed a top increase of 448595.84% in 2024 and a maximum decrease of 29407.95% in 2024.
  • Quarter analysis of 4 years shows BioRestorative Therapies' Cash from Investing Activities stood at -$3.2 million in 2022, then surged by 97.39% to -$84798.0 in 2023, then surged by 1907.36% to $1.5 million in 2024, then soared by 30.34% to $2.0 million in 2025.
  • Its Cash from Investing Activities stands at $2.0 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.4 million for Q1 2025.